Skip to main content

ENVESTNET ASSET MANAGEMENT INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1407543 Berwyn, PA

Position in NBIX

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$28,812,855
-$507,802 QoQ
Shares Held
218,710
+5.8% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $406,743,458 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
218,710 $28,812,855

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,812,855 218,710
2025-12-31 $29,320,657 206,731
2025-09-30 $28,475,521 202,846
2025-06-30 $24,891,521 198,039
2025-03-31 $13,527,043 122,306
2024-12-31 $27,738,165 203,210
2024-09-30 $26,908,478 233,540
2024-06-30 $27,918,512 202,793
2024-03-31 $27,500,834 199,397
2023-12-31 $26,297,451 199,586
2023-09-30 $21,694,950 192,844
2023-06-30 $7,753,346 82,220
2023-03-31 $41,174,474 406,782
2022-12-31 $14,746,898 123,467
2022-09-30 $13,204,345 124,323
2022-06-30 $12,304,510 126,226
2022-03-31 $11,291,437 120,442
2021-12-31 $7,238,598 84,990
2021-09-30 $9,413,566 98,150
2021-06-30 $8,858,358 91,023
2021-03-31 $8,611,390 88,549
2020-12-31 $7,661,098 79,928
2020-09-30 $7,649,912 79,554
2020-06-30 $5,754,740 47,170
2020-03-31 $3,759,905 43,442